Don’t Delay With Delta: Best Practices and Calls to Action in HDV

Download All
In this series of concise, engaging Medical Minutes and podcasts, hear from international experts on the global burden of HDV, risk factors and screening recommendations, new treatment options and current management recommendations, and the evolving therapeutic landscape. Gain patient perspectives to better understand the impact of disease and delays in diagnosis.
Kosh Agarwal, MD
Maria Buti, MD
Graham R. Foster, FRCP, PhD
Robert G. Gish, MD
Nancy Reau, MD
Heiner Wedemeyer, MD
Grace LH Wong, MD
Ming-Lung Yu, MD, PhD
person default
Cihan Yurdaydin, MD
Stefan Zeuzem, MD

Podcasts

Hepatitis delta is the most severe form of viral hepatitis, and many patients remain undiagnosed. Listen to experts discuss a call to action for universal screening of patients with hepatitis B for coinfection with hepatitis delta.

Maria Buti, MD Robert G. Gish, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: December 20, 2021 Expired: December 19, 2022

Few treatment options exist for HDV, but many promising investigational agents are on the horizon. Listen to experts discuss what questions still need to be answered to optimize treatment of HDV with current―as well as new and emerging―agents.

Nancy Reau, MD Stefan Zeuzem, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: March 3, 2022 Expired: March 2, 2023

The hepatitis delta virus (HDV) only coexists in patients chronically infected with hepatitis B virus (HBV). Listen to experts discuss steps to take for monitoring and treating both forms of viral hepatitis.

Heiner Wedemeyer, MD person default Cihan Yurdaydin, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: March 10, 2022 Expired: March 9, 2023

Several emerging agents will soon be available for the treatment of hepatitis delta virus (HDV). Hear experts discuss rational use and combinations of new agents to treat patients with HDV.

Heiner Wedemeyer, MD person default Cihan Yurdaydin, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: March 16, 2022 Expired: March 15, 2023

Listen as 2 experts discuss the importance of increasing healthcare professional and patient awareness of HDV to ensure that at-risk patients receive screening and then treatment and monitoring following a positive test.

Grace LH Wong, MD Ming-Lung Yu, MD, PhD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: May 3, 2022 Expired: May 2, 2023

Your patient tests positive for hepatitis delta virus (HDV). Now what? Listen as 2 experts discuss challenges and opportunities in linking patients with HDV to care.

Kosh Agarwal, MD Graham R. Foster, FRCP, PhD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: June 30, 2022 Expired: June 29, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by:
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings